Tesamorelin

Tesamorelin — GHRH Analog Research Peptide Research Use Only | ≥98% Purity

Tesamorelin is a synthetic analog of endogenous growth hormone releasing hormone (GHRH), comprising the full 44 amino acid GHRH sequence stabilized with a trans-3-hexenoic acid modification that enhances molecular stability and resistance to enzymatic degradation. As a highly specific GHRH receptor agonist, Tesamorelin has been extensively studied in preclinical and clinical research settings for its interactions with the hypothalamic-pituitary axis and downstream growth hormone secretion signaling pathways.

Tesamorelin is of particular research interest for its high receptor binding specificity and well-characterized pharmacokinetic profile, making it a valuable tool for investigators studying GHRH receptor pharmacology, pituitary somatotroph function, and growth hormone axis regulation in controlled laboratory models. Its structural modification distinguishes it from native GHRH and has made it a widely referenced compound in peptide stability and receptor binding research.

All USA Made Peps Tesamorelin is independently third-party tested to a minimum purity of ≥98% by HPLC and mass spectrometry and supplied with a full Certificate of Analysis.

Available size:

• Tesamorelin — 10mg per vial (10 vial pack) or Single Vial

Supplied as lyophilized powder. Store at -20°C. For research use only.

For Research Use Only. Not for human or animal use. Not FDA-approved. Not intended to diagnose, treat, cure, or prevent any disease or condition. For in vitro laboratory research purposes only. Buyer assumes full responsibility for lawful use in their jurisdiction.